Oakland, CA, United States of America

Zheng Li

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Oakland, CA (US) (2017 - 2018)
  • Urbana, IL (US) (2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of Inventor Zheng Li

Introduction

Zheng Li is an accomplished inventor based in Oakland, CA. He has made significant contributions to the field of detection methods and cancer treatment. With a total of 3 patents, his work showcases innovative approaches to complex scientific challenges.

Latest Patents

One of Zheng Li's latest patents focuses on methods and devices for the detection of trimethylamine (TMA) and trimethylamine oxide (TMAO). This patent provides methods for detection and quantification of TMA or TMAO by passing a sample over a sensor that includes a substrate with a variety of chemically responsive dyes. These dyes can be metal-containing, pH indicators, or solvatochromic/vapochromic dyes. Additionally, the patent outlines devices and sensors for diagnosing subjects with trimethylaminuria (TMAU). Another notable patent involves deoxycytidine kinase inhibitors, which are compounds that bind to dCK and offer methods for treating cancer.

Career Highlights

Zheng Li has worked at prestigious institutions such as the University of Illinois and the University of California. His research has contributed to advancements in both detection technologies and cancer therapies.

Collaborations

Throughout his career, Zheng Li has collaborated with notable colleagues, including Caius G Radu and Raymond M Gipson. These partnerships have further enhanced the impact of his work in the scientific community.

Conclusion

Zheng Li's innovative patents and career achievements reflect his dedication to advancing technology in detection methods and cancer treatment. His contributions continue to influence the fields of science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…